• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA clears Medtronic’s PillCam system for remote endoscopy procedures

FDA clears Medtronic’s PillCam system for remote endoscopy procedures

November 15, 2021 By Sean Whooley

Medtronic PillCam SB3 2021 (1)
[Image from Medtronic]
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its PillCam Small Bowel 3 system for remote endoscopy procedures.

PillCam SB3 @Home program works with Amazon logistics to ensure timely and accurate results for patients undergoing remote endoscopy procedures from the comfort of their own homes, according to a news release.

The platform offers a telehealth option for the direct visualization and monitoring of the small bowel. Medtronic said it helps to better detect lesions not detected by upper and lower endoscopy that may indicate Crohn’s disease, locate obscure bleeding or identify sources of iron deficiency anemia (IDA).

PillCam SB3 is delivered straight to a patient and, via a telehealth appointment, a provider guides the patient through the remote procedure. Over the course of the eight-hour procedure, the PillCam SB3 capsule transmits approximately 50,000 images securely to the cloud where they can be assessed by a GI physician to make a diagnosis. The patient returns the data recorder and sensor belt to Medtronic once the procedure is complete.

The SB3 @Home platform previously held temporary FDA approval during the National Public Health Emergency, while Medtronic’s PillCam capsule endoscopy has been in use for more than 20 years. PillCam SB is now in its third generation and only holds clearance for remote use in the U.S. and not in other geographies.

“As the future of medicine continues to move toward remote settings, we have great opportunity to deliver diagnostic testing and other minimally invasive procedures from patients’ homes,” Medtronic Gastrointestinal Business President Giovanni Di Napoli said in the release. “The pandemic necessitated more remote innovation, and our capabilities have exceeded expectations to provide better quality care to patients without the risk of COVID infection and without adding to the burden on the medical staff. PillCam SB3 @Home offers a convenient option for a contactless procedure and helps ensure that patients can access care in a timely manner.”

Filed Under: 510(k), Diagnostics, Digital Health, Endoscopic, Featured, Food & Drug Administration (FDA), Health Technology, Imaging, Men's Health, Regulatory/Compliance, Women's Health Tagged With: Medtronic

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy